Phase I trial of o6-benzylguanine and BCNU [carmustine ]: a biochemical modulation trial based upon depletion of o6-alkylguanine DNA alkyltransferase directed dna repair.

Trial Profile

Phase I trial of o6-benzylguanine and BCNU [carmustine ]: a biochemical modulation trial based upon depletion of o6-alkylguanine DNA alkyltransferase directed dna repair.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Mar 2010

At a glance

  • Drugs Benzylguanine (Primary) ; Carmustine (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Mar 2010 Actual end date (Feb 2004) added as reported by ClinicalTrials.gov.
    • 01 Sep 2006 Status change
    • 21 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top